Zalcitabine or 2',3'-dideoxyinosine was the third drug approved by the FDA to fight the HIV virus. The Triphosphate manifestation of zalcitabine inhibits hiv reverse transcriptase Toward contending to consolidation under viral dna and additionally chain end of the viral dna because of the absence of a 3'-OH aggregation.
